Navigation Links
Aware to Showcase DSL Test Solutions for IPTV Services at IP&TV World Forum
Date:3/21/2011

e factors that could cause actual results to differ materially from the results indicated by such statements. General factors include, but are not limited to: our quarterly results are unpredictable and may fluctuate significantly; our business is subject to rapid technological change; adverse economic conditions could harm our business; our intellectual property is subject to limited protection; our business may be adversely affected by our use of open source software; and our business may be affected by government regulations. DSL test and diagnostic factors include, but are not limited to: our DSL test and diagnostic businesses depend upon a limited number of customers; our DSL test and diagnostics business faces intense competition; the success of our DSL test and diagnostics products businesses requires telephone companies to install DSL service in volume; the success of our DSL test and diagnostic product depends on our ability to develop commercially viable products in a timely fashion; our test and diagnostic hardware and software products could have quality problems; we depend on a single source contract manufacturer for the manufacture of our DSL hardware products; our manufacturing systems may not be adequate for our DSL test and diagnostics hardware product offerings; and we are dependent on single source suppliers for components in our DSL hardware products. We refer you to the documents Aware files from time to time with the Securities and Exchange Commission, specifically the section titled Risk Factors in our annual report on Form 10-K for the fiscal year ended December 31, 2010 and other reports and filings made with the Securities and Exchange Commission.

Aware, and Dr. DSL are trademarks or registered trademarks of Aware, Inc. Any other trademarks appearing herein are the property of their respective owners.


'/>"/>
SOURCE Aware, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. Aware Announces Q3 2008 Earnings Conference Call
2. Aware Announces Q4 and FY2008 Earnings Conference Call
3. African-Americans aware and accepting, but often do not receive, the HPV vaccine
4. Aware, Inc. Reports Fourth Quarter and 2008 Financial Results
5. Aware, Inc. Commences Dutch Auction Tender Offer
6. Aware, Inc. Commences Dutch Auction Tender Offer
7. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
8. TGen helps promote cancer awareness for vast Navajo Nation
9. Aware, Inc. Announces Preliminary Results of Dutch Auction Tender Offer
10. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
11. Aware, Inc. Announces Q1 09 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... The global genomics market was valued at $11.11 billion ... CAGR of over 12.0% from 2013 to 2018. The ... applications, and advancements in existing technologies plays an important ... this market. Next Generation Sequencing (NGS) in personalized medicine ... area for the global genomics market. This new technology ...
(Date:10/1/2014)... Reserve University researchers hope to take a healthy salad ... aggressive form of breast cancer in leafy greens. , ... the vaccine either by eating the salad or making ... assistant professor of biomedical engineering at Case Western Reserve ... The Susan G. Komen breast cancer organization is funding ...
(Date:10/1/2014)... Novel detection technology is ... The life science field has seen ... years. Some are shooting stars and others become ... detection technology that has raised much enthusiasm among ... is becoming commercially available. With their unique advantages, ...
Breaking Biology News(10 mins):Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) - Global Forecast to 2018 2Scientists wield plant viruses against deadly human disease 2Scientists wield plant viruses against deadly human disease 3First-of-a-kind Solution for Utilizing Photon Upconversion 2
... The International Council for Science (ICSU), within ... major 10-year initiative which aims to effectively deliver ... This new international collaboration effort, the Earth System ... to respond to the most pressing societal and ...
... key regulator that controls the speed of development in the ... regulator, animals sped up their rate of development and reached ... A research team, led by molecular geneticist Kirst King-Jones, noticed ... The protein acted as a sentinel to either allow or ...
... inequality around the world, the Journal of Visualized ... through the HINARI initiative to developing countries in South ... in biological research, JoVE is the first and only ... publishes video articles demonstrating advanced experiments performed in laboratories ...
Cached Biology News:Research solutions for sustainability in a rapidly changing world 2JoVE grants developing countries access to experimental videos 2
(Date:10/1/2014)... October 01, 2014 TeselaGen Biotechnology ... Science Foundation to expand their bioCAD/CAM software suite, which ... modify DNA. The Small Business Innovation Research Phase II ... technology under exclusive license from the Lawrence Berkeley National ... Institute , an LBNL laboratory that develops alternative fuel ...
(Date:10/1/2014)... 1, 2014 Industry leaders ... to engage around the theme, ,Commercial Opportunities in the ...   Elsevier , a world-leading provider ... will host a gathering of some of the industry,s ... impacting healthcare today and in the future. The ...
(Date:9/30/2014)... news release is available in German . ... the Technische Universitt Mnchen (TUM) have demonstrated a new ... experiments show that future computer chips could be based ... As the main enabling technology of the semiconductor industry ... limits, the TUM researchers and collaborators at the University ...
(Date:9/30/2014)... 2014 Report Details Biosimilar drugs ... revenues Do you want to find sales potentials ... predictions for those biological drugs from 2014, helping ... financial data, R&D trends, opportunities and selling prospects. ... to 2024 at overall world market, therapeutic class, ...
Breaking Biology Technology:TeselaGen Receives $750k NSF SBIR Phase II Award 2TeselaGen Receives $750k NSF SBIR Phase II Award 3Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 2Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 3A new dimension for integrated circuits: 3-D nanomagnetic logic 2A new dimension for integrated circuits: 3-D nanomagnetic logic 3Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 2Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 3Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 4Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 5
... ATLANTA, Georgia , March 14, 2010 ... type 2 diabetes patients with,atherogenic dyslipidemia, the common combination of ... low levels of high-density,lipoprotein cholesterol (HDL-C, 34 mg/dL or 0.88 ... Only 20 of these patients need,to be treated for 5 ...
... ... is taking strides to expand their Product and Material Testing Division by promoting Mark Francis ... Minneapolis, ... and material testing, is taking strides to expand their Product and Material Testing Division by ...
... FRANCISCO , March 12 Medivation, Inc. (Nasdaq: MDVN ) today announced that it will ... a general business update on March 15, 2010 , at 4:30 p.m. Eastern Time . A ... after markets close on March 15, 2010 . , ... ...
Cached Biology Technology:ACCORD Lipid Study Brings new Hope to People With Type 2 Diabetes and Atherogenic Dyslipidemia Says International Academic Foundation 2ACCORD Lipid Study Brings new Hope to People With Type 2 Diabetes and Atherogenic Dyslipidemia Says International Academic Foundation 3ACCORD Lipid Study Brings new Hope to People With Type 2 Diabetes and Atherogenic Dyslipidemia Says International Academic Foundation 4ACCORD Lipid Study Brings new Hope to People With Type 2 Diabetes and Atherogenic Dyslipidemia Says International Academic Foundation 5ACCORD Lipid Study Brings new Hope to People With Type 2 Diabetes and Atherogenic Dyslipidemia Says International Academic Foundation 6ACCORD Lipid Study Brings new Hope to People With Type 2 Diabetes and Atherogenic Dyslipidemia Says International Academic Foundation 7ACCORD Lipid Study Brings new Hope to People With Type 2 Diabetes and Atherogenic Dyslipidemia Says International Academic Foundation 8ACCORD Lipid Study Brings new Hope to People With Type 2 Diabetes and Atherogenic Dyslipidemia Says International Academic Foundation 9DDL Expands the Product & Material Testing Division 2DDL Expands the Product & Material Testing Division 3Medivation Announces Fourth Quarter and Year-End 2009 Financial Results Teleconference and Webcast On March 15, 2010 2Medivation Announces Fourth Quarter and Year-End 2009 Financial Results Teleconference and Webcast On March 15, 2010 3
... Rabbit polyclonal to Taura ... Abpromise for all tested ... Synthetic peptide: VTNSEGSTIL MNDIPITNQN ... ATEFNQ, corresponding to N terminal ...
Goat polyclonal to SART3 ( Abpromise for all tested applications). Antigen: Synthetic peptide: MSNADFAKLFLRK, corresponding to C terminal amino acids 951-963 of Human SART3 Entrez Gene ID: 9...
... Anti-acetyl-Histone H3 (Lys 4) ... the sequence ...RT[ Ac K]Q... in which ... 4 of human histone H3 ... Molecular Weight: Mr ~17kDa ...
Blank Calibration Particles, 3.0-3.4 mu m 5 ml...
Biology Products: